Back to Trades
CHASE WILLIAM J
DirectorCIK 0001563572
Profile
- Filings
- 7
- Buy transactions
- 1
- Sell transactions
- 0
- Companies
- 2
- Active
- 2025–2026
CHASE WILLIAM J, Director, has filed 7 SEC reports (2025–2026), spread across 2 companies, totaling $1.6M in disclosed volume. Weighing $1.0M bought versus $0 sold, the history is heavily weighted toward buying. The largest single open-market purchase on record is $1.0M in Intellia Therapeutics, Inc.. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
7 loaded
| Jul 16 | GRAL GRAIL, Inc. | CHASE WILLIAM J | Director | Grant | $20.5K |
| Jun 22 | GRAL GRAIL, Inc. | CHASE WILLIAM J | Director | Grant | $350.0K |
| Jun 10 | NTLA Intellia Therapeutics, Inc. | CHASE WILLIAM J | Insider | Grant | $171.4K |
| Jan 16 | GRAL GRAIL, Inc. | CHASE WILLIAM J | Director | Grant | $20.8K |
| Oct 16 | GRAL GRAIL, Inc. | CHASE WILLIAM J | Director | Grant | $20.8K |
| Aug 22 | NTLA Intellia Therapeutics, Inc. | CHASE WILLIAM J | Insider | Buy | $1.0M |
| Jul 17 | GRAL GRAIL, Inc. | CHASE WILLIAM J | Director | Grant | $20.5K |
7 filings